ReviewFrontiers in neuroscience2022

Quantitative susceptibility mapping as an imaging biomarker for Alzheimer's disease: The expectations and limitations.

Yuto Uchida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.